Home TeneoTwo

TeneoTwo

In operation
-
Developer of New Drugs for Malignant Tumor Treatment
Basic
Enterprise Profile

Basic Information

TeneoTwo is a biotechnology company dedicated to developing potential new drugs for B-cell hematologic malignancies, including diffuse large B-cell lymphoma and follicular lymphoma.
TeneoTwo Inc.
California,United States of America
unclear
--
--
--

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial Biological Drug Production
Concept
Tumor Lymphoma
Application Scenarios
Innovative Drugs